News | Ultrasound Imaging | November 16, 2023

Combining image clarity and advanced automated features, the V6 offers efficient, comprehensive imaging capabilities for daily ultrasound scanning needs 

The V6 ultrasound system is specifically designed to offer clinicians a versatile solution that efficiently supports the daily clinical demands in Women’s Health and Urology.

The V6 ultrasound system is specifically designed to offer clinicians a versatile solution that efficiently supports the daily clinical demands in Women’s Health and Urology. (Photo: Business Wire) 


November 16, 2023 — Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, today announced the launch of the V6, its latest ultrasound system that delivers comprehensive imaging capabilities in 2D, 3D and color image quality, tailored for Women's Health and Urology. The V6 recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use and is designed to be budget-friendly while meeting workflow and productivity needs. 

“We are thrilled to introduce our latest innovation in Women's Health and Urology imaging, reflecting our unwavering commitment to delivering efficient care and meeting the imaging demands of medical professionals,” said David Legg, Head of Boston Imaging. “The V6 provides advanced healthcare technology to clinicians, enabling them to provide a high standard of care.” 

In addition to enhancing image clarity and accuracy, the V6 is adaptable in various medical settings through its remote access, simplified workflows, wide screen and compact, powerful design with a battery option, increasing accessibility and versatility for healthcare providers. 

“The V6 was developed with the clinical needs of Women’s Health and Urology specifically in mind,” said Tracy Bury, Women’s Health Segment Leader for Boston Imaging. “We’re proud to offer a new product that is not only accessible to a broad group of clinicians but also has innovative, automated features that can make patient care simpler and more efficient.” 

The V6 ultrasound system is driven by Samsung’s core imaging platform, Crystal Architecture, offering both enhanced image clarity and advanced automated tools, including: 

  • miniER7 Endocavity Transducer: Small design for patient comfort, 180° field of view for wide angle imaging and a 2-12 MHz frequency range to fulfill a variety of imaging needs. According to a recently published study1, utilizing the probe with a 63% reduced head volume not only led to a significant 43% decrease in patient discomfort during prostate ultrasounds without impacting image quality, but it is also expected to potentially minimize pain during pelvic examinations in menopausal women. 
  • ViewAssist: An artificial intelligence (AI) feature that automatically recognizes imaging planes and labels anatomy to ease healthcare professionals’ documentation and enhance exam workflow. 
  • BiometryAssist: A semi-automated feature, based on Deep Learning, that enables one-click fetal growth measurements to provide exam consistency while reducing keystrokes, allowing physicians to focus more on patient care. 
  • UterineAssist: An AI technology tool to automatically measure the size and shape of the uterus, assisting in detecting signs of uterine-related abnormalities. 
  • Mobile Export: A secure image-sharing solution using a simple QR code to transfer fetal images from the ultrasound system directly to the patient’s smartphone making images instantaneously shareable to friends and family. 
  • SonoSync: A real-time image share solution that allows communication for care guide and training between doctors and sonographers. In addition, voice chatting, text chatting and real-time marking functions are provided for better communication. 

The V6 has been evaluated for acoustic output, biocompatibility, software function, cleaning and disinfection effectiveness as well as thermal, electrical, electromagnetic and mechanical safety, and conforms with applicable FDA guidances and medical device safety standards. It also comes with a comprehensive selection of transducers that can be used for a variety of clinical needs. The V6 is compatible with Cycle Clarity’s AI-based software platform making it an excellent fit in the reproductive endocrinology and infertility setting. 

Reference: 

1 Hwang SI, Ahn H, Lee HJ, Jung SI. Comparative study of standard and small transrectal transducers for prostate ultrasonography. Ultrasonography. 2023 Oct;42(4):555-560. 

For more information: www.bostonimaging.com 

Find more RSNA23 conference coverage here 


Related Content

News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Subscribe Now